Turning Point Therapeutics Reports Third-Quarter Financial Results, Provides Operational Updates

NEXT STORY
ChemoCentryx Reports Third Quarter 2021 Financial Results and Recent Highlights
PREV STORY
GeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche announces new data at the ISTH 2020 Congress, demonstrating ongoing commitment to advancing care for people with haemophilia A

author_avatar
NASDAQ Market News

PDS Biotech Collaborator Granted NIAID Award to Accelerate Development of Versamune®-Based Universal Influenza Vaccine

author_avatar
NASDAQ Market News

New Preclinical Data Demonstrate Potential of Codiak’s Engineered Exosomes as Novel, Targeted Approaches in Multiple Disease Areas

author_avatar
NASDAQ Market News